A research study demonstrated that viloxazine (Qelbree) significantly reduced executive function deficits in children, though the caveat is that these results may not always generalize to adults; however, the pharmacological profile suggesting improvement in executive dysfunction is promising enough to warrant clinical trials in adults.

factualpending

Speaker

Dr. Tracey Marks

Evidence Quote

“Qelbree significantly reduced executive function deficits”

Source

Rethinking ADHD Treatment: The Power of Non-Stimulant Medication— Dr. Tracey Marks
Created: 8/11/2026, 5:26:50 AM

Your notes

Loading notes...